Modern Diagnostic & Research Centre Limited (MDRC), a prominent player in India’s diagnostic healthcare sector, is set to open its Initial Public Offering (IPO) on December 31, 2025. The development was first reported in an article titled “Modern Diagnostic & Research Centre Limited IPO opens on December 31, 2025” by startupnews.fyi.
The Gurugram-based company is offering a public issue that includes a fresh allotment of equity shares and an Offer For Sale (OFS) by its existing shareholders. Proceeds from the IPO are expected to be channeled into expanding the company’s diagnostic facilities, investing in new technologies, and reducing outstanding debt, according to details cited in the original report.
MDRC, founded in 1985, has established itself as a trusted healthcare diagnostics brand in Northern India, offering a wide array of services including radiology, pathology, and specialized health screenings. In recent years, the company has reportedly experienced significant revenue growth driven by increased demand for preventative healthcare and precision diagnostics.
This IPO entry comes amid a generally active period for India’s healthcare sector, where diagnostic firms have witnessed heightened investor interest owing to their high-margin business models and recurring customer bases. Analysts believe that MDRC, with its long-standing reputation and established operational footprint, is well-positioned to leverage public funding to deepen its market penetration and enhance service delivery.
While the company has yet to disclose pricing and valuation details, industry observers are closely watching the IPO for signs of broader investor sentiment towards mid-sized healthcare firms looking to scale. The diagnostic services market in India is estimated to be worth over USD 10 billion and continues to grow, underscoring the strategic timing of MDRC’s public listing.
The IPO is expected to close on January 2, 2026, and is being managed by a consortium of investment banks and underwriters with experience in healthcare sector listings. If market conditions remain favorable, the offering could mark a significant step in MDRC’s transition from a regional player to a pan-India diagnostic leader.
Investors and analysts alike will be monitoring how the offering is received, both as an indicator of MDRC’s valuation prospects and as a harbinger of market appetite for healthcare IPOs in the months ahead.
